![Slide 1 Slide 1](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000001.jpg)
REVA FANTOM II Performance and healing patterns by OCT Two-year serial follow-up Emil Nielsen Holck, Jo Simonsen, Didier Carrié, Nobert Frey, Matthias Lutz, Joachim Weber-Albers, Darius Dudek, Bernard Chevalier, Jouke Dijkstra, Jens Lassen, Jeffrey Anderson, Joest daemen, Evald Høj Christiansen, Alexandre Abizaid, Niels Ramsing Holm On behalf of the FANTOM II investigators Niels Ramsing Holm Aarhus University Hospital, Denmark Exhibit 99.3
![Slide 2 Slide 2](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000002.jpg)
The FANTOM BRS Desaminotyrosine based polycarbonate backbone Strut thickness 125µm Sirolimus eluting for 3 months Full resorption within 3-4 years FANTOM II
![Slide 3 Slide 3](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000003.jpg)
FANTOM angiographic signature Radiopacity Covalently bound iodine in the polycarbonate backbone FANTOM II
![Slide 4 Slide 4](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000004.jpg)
FANTOM BRS by 3D OCT FANTOM II 3D OCT by St Jude OPTIS
![Slide 5 Slide 5](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000005.jpg)
FANTOM OCT signature Baseline 6 month FU FANTOM II 24 month FU
![Slide 6 Slide 6](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000006.jpg)
REVA FANTOM II – OCT analysis PCI Research Aarhus University Hospital, Skejby ● Denmark OCT billede af baseline og FU strut
![Slide 7 Slide 7](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000007.jpg)
Customized analysis Lumen Abluminal stent Luminal stent Stent strut QCU-CMS, Leiden University Medical Center, The Netherlands
![Slide 8 Slide 8](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000008.jpg)
REVA FANTOM II SKEJBY PCI Research Aarhus University Hospital, Skejby ● Denmark Strut thickness by micro-CT OCT analysis optimized and validated by micro-CT FANTOM II
![Slide 9 Slide 9](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000009.jpg)
REVA FANTOM II PCI Research Aarhus University Hospital, Skejby ● Denmark OCT analysis optimized and validated by micro-CT FANTOM II
![Slide 10 Slide 10](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000010.jpg)
REVA FANTOM II PCI Research Aarhus University Hospital, Skejby ● Denmark Baseline FU FANTOM II
![Slide 11 Slide 11](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000011.jpg)
Micro-CT FANTOM in bifurcations FANTOM II
![Slide 12 Slide 12](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000012.jpg)
FANTOM II Patient flow chart
![Slide 13 Slide 13](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000013.jpg)
FANTOM II Analysis flow chart TLR
![Slide 14 Slide 14](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000014.jpg)
Mean scaffold area FANTOM II 7.32±1.14 mm2 7.43±1.19 mm2 7.45±1.28 mm2
![Slide 15 Slide 15](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000015.jpg)
Minimal scaffold area FANTOM II 6.14±1.09 mm2 6.25±1.16 mm2 5.99±1.17 mm2
![Slide 16 Slide 16](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000016.jpg)
Mean lumen area FANTOM II 7.09±1.38 mm2 6.01±1.32 mm2 5.87±0.19 mm2
![Slide 17 Slide 17](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000017.jpg)
Minimal lumen area FANTOM II 5.58±1.09 mm2 4.65±1.10 mm2 4.10±1.21 mm2
![Slide 18 Slide 18](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000018.jpg)
Malapposition FANTOM II 0.6% [0.0;4.6] 0.0% [0.0;0.0] 0.0% [0.0;0.0] p=0.67 p<0.001
![Slide 19 Slide 19](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000019.jpg)
Extra-stent lumen 24 months follow-up cohort baseline 6 months 24 months Extra stent lumen area (mm2) 0.04[0.03;0.19] 0.01[0.00;0.03] 0.00[0.00;0.01] FANTOM II p<0.001 p=0.05
![Slide 20 Slide 20](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000020.jpg)
Extra-stent lumen FANTOM II No evaginations or late scaffold detachment after 24 months Example in permanent DES. Radu et al. EHJ 2017
![Slide 21 Slide 21](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000021.jpg)
Neointimal area 24 months follow-up cohort 6 months 24 months p-value Mean neointimal area (mm2) 1.20±0.31 1.52±0.37 <0.001 FANTOM II Blue area: Neointimal area
![Slide 22 Slide 22](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000022.jpg)
Neointimal thickness 24 month follow-up cohort 6 months 24 months p-value Mean neointimal thickness (µm) 51[36;67] 79[53;110] 0.01 Median (IQR) FANTOM II
![Slide 23 Slide 23](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000023.jpg)
Strut coverage Strut-level results in 24m follow-up cohort FANTOM II 98.6% [96.5;99.7] 100% [100;100]
![Slide 24 Slide 24](https://capedge.com/proxy/8-K/0001564590-18-014171/g5d212kffvmh000024.jpg)
Conclusion Complete strut coverage Slight decrease in lumen area due to limited additional neointimal growth – mainly in cases with small acute MLA No stent area reduction – no late recoil Excellent resolution of acute malapposition and still no acquired malapposition and no evaginations detected after 24 months The Fantom BRS show promising healing patterns after 24 months: